Kirby Corp (KEX) 82.31 $KEX This Wonderful Company Is

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kirby Corp (KEX) 82.31 $KEX

This Wonderful Company Is Modestly Undervalued
Rami Alsamaraee - at Seeking Alpha - Tue Apr 21, 3:54AM CDT

KEX: 82.31 (-1.59)

After Yesterday's Rally of 2.51% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Apr 07, 5:31PM CDT
Kirby (NYSE:KEX) traded in a range yesterday that spanned from a low of $74.87 to a high of $76.96. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $75.10 on volume of 711,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
KEX: 82.31 (-1.59)

Skidding Prices Have Brought Rare Sanity To Kirby's Valuation
Stephen Simpson, CFA - at Seeking Alpha - Tue Apr 07, 11:04AM CDT

KEX: 82.31 (-1.59)

Kirby Corporation To Announce 2015 First Quarter Results On April 29, 2015 With Conference Call On April 30, 2015
PR Newswire - Mon Apr 06, 2:29PM CDT
Kirby Corporation ("Kirby" (NYSE: KEX) will announce its 2015 first quarter results at 4:00 p.m. central time on Wednesday, April 29, 2015. A conference call to discuss the results will be held at 7:30 a.m. central time on Thursday, April 30, 2015.
KEX: 82.31 (-1.59)

Insider Trading Alert - KEX, KFRC And ALGT Traded By Insiders
at The Street - Wed Feb 18, 11:30AM CST
Stocks with insider trader activity include KEX, KFRC and ALGT
KFRC: 22.07 (+0.04), KEX: 82.31 (-1.59), ALGT: 168.12 (+1.10)

Major Stock Indexes Struggle; Apple And Starbucks Up
at Investor's Business Daily - Wed Feb 18, 11:01AM CST
The Nasdaq was on track midday Wednesday to break its five-session win streak, though close enough to the break-even line to leave the outcome in doubt. Volume was running about 10% lower vs. the previous day's pace. The S&P 500 and Dow Jones...
SBUX: 51.84 (+2.41), CAVM: 65.63 (-4.51), V: 67.48 (-0.24), KEX: 82.31 (-1.59), AAPL: 130.28 (+0.61)

Kirby Corporation: Take Note Of This High-Quality Business Being Offered At A Fair Price
ValueArtifex - at Seeking Alpha - Wed Feb 18, 10:01AM CST

KEX: 82.31 (-1.59)

Kirby Shares Down 25.4% Since SmarTrend's Sell Call (KEX)
Comtex SmarTrend(R) - Fri Feb 13, 9:47AM CST
SmarTrend identified a Downtrend for Kirby (NYSE:KEX) on November 5th, 2014 at $105.00. In approximately 3 months, Kirby has returned 25.36% as of today's recent price of $78.38.
KEX: 82.31 (-1.59)

Kirby Down 25.7% Since SmarTrend Downtrend Call (KEX)
Comtex SmarTrend(R) - Fri Feb 06, 9:18AM CST
SmarTrend identified a Downtrend for Kirby (NYSE:KEX) on November 5th, 2014 at $105.01. In approximately 3 months, Kirby has returned 25.66% as of today's recent price of $78.06.
KEX: 82.31 (-1.59)

Research and Markets: Barge Transportation Market in the US 2015-2019 with AEP River Operations, American Commercial Lines LLC, Ingram Barge Company & Kirby Corp. Dominating
Business Wire - Fri Feb 06, 5:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/szm3k7/barge) has announced the addition of the "Barge Transportation Market in the US 2015-2019" report to their offering.
KEX: 82.31 (-1.59)

Barge Transportation Market in the US 2015-2019 with AEP River Operations, American Commercial Lines LLC, Ingram Barge Company & Kirby Corp. Dominating
M2 - Fri Feb 06, 5:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/wvcnjl/barge) has announced the addition of the "Barge Transportation Market in the US 2015-2019" report to their offering. This report covers the present scenario and the growth prospects of the Barge Transportation market in the US for 2015-2019. To calculate the market size, it considers the volume of trade conducted through different types of barges. It presents an in-depth analysis of different types of barges used in the market and products transported through barges. Rise in investment for construction of new tank barges has propelled the growth of the market. Increased crude oil production in the US has surged demand for the usage of tank barges through inland waterway transportation. Many vendors in the market have started to provide shipping services for transportation of liquid-bulk cargo. According to the report, one of the main drivers in the Barge Transportation market in the US is increased production of domestic crude oil in the US. Growth of the Crude Oil market in the US because of development of oil rigs has surged demand for transportation of these crude oils to refineries through tank barges. Further, the report states that the capital-intensive nature of barge transportation services is one of the major challenges hindering its growth. The manufacturing and maintenance of barges require huge capital investment. Also, the high operational cost of barges leads to an increase in the CAPEX of companies. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The Barge Transportation market in the US is segmented as follows according to type of barge fleets available in the market: - Covered Barge - Open Barge - Tank Barge The Barge Transportation market in the US is segmented as follows according to the type of products transported through different barges: - Chemicals and Allied Products - Coal - Crude Materials - Food and Farm Products - Petroleum Products - Others Key Vendors - AEP River Operations - American Commercial Lines LLC - Ingram Barge Company - Kirby Corp. Other Prominent Vendors - AgriChem Marine Transportation - Alter Logistics - Argosy Transportation - ATS International Services - Barge America - Blessey Marine Services - Bouchard Transportation - Campbell Transportation - Canal Barge - Ceres Barge Lines - Crounse Corporation - Heartland Barge - McAllister Towing and Transportation - SCF Marine For more information visit http://www.researchandmarkets.com/research/wvcnjl/barge
KEX: 82.31 (-1.59)

Kirby Corporation To Present At The BB&T Capital Markets Transportation Services Conference
PR Newswire - Tue Feb 03, 8:52AM CST
Kirby Corporation ("Kirby" (NYSE: KEX) announced today that Kirby will attend the Stifel Nicolaus Transportation & Logistics Conference and present at the BB&T Capital Markets Transportation Services Conference. Specifics of the conference are as follows:
KEX: 82.31 (-1.59)

Bulk commodity rates fall to 30-year lows
Seeking Alpha - at Seeking Alpha - Fri Jan 30, 1:58PM CST

EGLE: 8.50 (-0.19), FREE: 0.03 (-0.01), PRGN: 0.75 (+0.03), ESEA: 0.74 (-0.02), NMM: 13.04 (+0.13), BALT: 1.61 (-0.04), SALT: 2.48 (+0.14), DCIX: 2.56 (-0.03), KEX: 82.31 (-1.59), ULTR: 1.36 (-0.04), DAC: 6.42 (+0.05), DSX: 6.21 (-0.03), SHIP: 0.77 (unch), NM: 3.98 (+0.03), GSL: 5.46 (+0.13), SBLK: 3.87 (unch), SINO: 1.52 (+0.07), DRYS: 0.73 (+0.02), SB: 3.81 (+0.05)

Kirby Down 30.9% Since SmarTrend Downtrend Call (KEX)
Comtex SmarTrend(R) - Thu Jan 29, 4:50PM CST
SmarTrend identified a Downtrend for Kirby (NYSE:KEX) on November 5th, 2014 at $105.01. In approximately 3 months, Kirby has returned 30.87% as of today's recent price of $72.59.
KEX: 82.31 (-1.59)

After Yesterday's Decline of 3.87%, Kirby Offers Investors Better Value
Comtex SmarTrend(R) - Thu Jan 29, 4:19PM CST
Kirby (NYSE:KEX) traded in a range yesterday that spanned from a low of $70.89 to a high of $76.00. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $75.06 on volume of 2.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
KEX: 82.31 (-1.59)

Kirby's (KEX) CEO David Grzebinski on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 29, 11:15AM CST

KEX: 82.31 (-1.59)

Kirby beats Street 4Q forecasts
Automated Insights - Wed Jan 28, 5:22PM CST
HOUSTON (AP) _ Kirby Corp. (KEX) on Wednesday reported fourth-quarter earnings of $68.1 million.
KEX: 82.31 (-1.59)

Kirby beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 4:03PM CST

KEX: 82.31 (-1.59)

Kirby Corporation Announces Record 2014 Fourth Quarter And Year Results
PR Newswire - Wed Jan 28, 4:00PM CST
Kirby Corporation ("Kirby" (NYSE: KEX) today announced record net earnings attributable to Kirby for the fourth quarter ended December 31, 2014 of $68.1 million, or $1.19 per share, compared with $64.3 million, or $1.13 per share, for the 2013 fourth quarter. Consolidated revenues for the 2014 fourth quarter increased 18% to $668.3 million compared with $568.4 million reported for the 2013 fourth quarter. Kirby also reported record net earnings attributable to Kirby for the 2014 year of $282.0 million, or $4.93 per share, compared with $253.1 million, or $4.44 per share, for 2013 which included a $0.20 per share benefit due to the reduction of the United earnout liability. Consolidated revenues for 2014 were $2.57 billion compared with $2.24 billion for 2013.
KEX: 82.31 (-1.59)

Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 4:35PM CST

GHL: 43.08 (+0.26), SLG: 128.82 (+1.47), AMP: 127.75 (+0.58), CTXS: 66.99 (-0.35), NOW: 76.09 (-0.79), MKSI: 35.94 (+0.44), EXTR: 2.55 (-0.02), CAVM: 65.63 (-4.51), VRTX: 133.20 (-2.62), ESIO: 5.91 (+0.01), JEC: 46.31 (-0.85), TTEK: 25.14 (+0.09), FB: 81.53 (-0.88), PTC: 37.18 (-0.18), CLB: 124.69 (-0.63), UMPQ: 17.18 (-0.08), IEX: 75.89 (-0.48), VAR: 95.50 (-0.64), AVB: 171.27 (+0.04), AZPN: 41.08 (-0.35), AF: 13.05 (-0.06), CGI: 27.06 (-0.20), SHOR: 7.01 (+0.06), FLEX: 12.35 (-0.18), CSII: 37.22 (-2.00), CPT: 77.27 (-0.17), KEX: 82.31 (-1.59), LVS: 55.25 (+0.13), TSCO: 90.98 (-0.28), STLD: 21.86 (-0.12), DHT: 7.88 (+0.03), MUR: 48.07 (-1.29), SWFT: 25.78 (-0.51), ALB: 59.00 (+0.05), IBKC: 62.86 (-0.61), QCOM: 68.24 (-0.10), CACI: 89.10 (-0.81), QGEN: 24.83 (-0.07), TER: 18.39 (-0.34), MEOH: 57.96 (+1.88), DRE: 20.42 (+0.04), SGI: 9.54 (-0.03), TGI: 60.36 (-0.35), CMO: 11.97 (+0.01), ATK: 140.03 (+0.78), ISIL: 14.16 (-0.54), ALGT: 168.12 (+1.10), GGP: 28.78 (+0.05), PRXL: 67.49 (+0.27), LRCX: 76.70 (-0.38), CRUS: 33.77 (-0.59), MLNX: 48.40 (-1.45), FTNT: 38.68 (-0.04), CBT: 45.68 (-0.13), HOLX: 33.99 (+0.57)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 273

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 240

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 167

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 0

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 121

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 120

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 184

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 208

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 135

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading

Top 5 Most Recently Viewed Articles

MAAS Embraces Healthcare with Strategic Carve Group Acquisition

Updated Category News Views 117

MAAS Expands into Healthcare and Wellness Maase Inc. (NASDAQ: MAAS) recently announced a significant expansion into the healthcare and wellness sector following its acquisition of Carve Group Ltd. This strategic move signifies MAAS's commitment to innovate within the traditional wellness product landscape by integrating advanced biotechnology. The acquisition is more than...

Continue Reading
Metavesco Welcomes ADHC's Strategic Purchase of OTCfi Tokens

Updated Category News Views 117

Metavesco Celebrates Collaboration with ADHC In a significant development, Metavesco, Inc. (NASDAQ: MVCO) recently expressed excitement over American Diversified Holdings Corporation (NASDAQ: ADHC) announcing their Digital Asset Treasury (DAT) purchase of OTCfi tokens. This partnership is seen as a positive move towards enhancing the visibility and growth of the...

Continue Reading
Understanding Short Interest Trends in Discover Financial

Updated Category News Views 188

Understanding Short Interest Trends in Discover Financial Discover Financial's stock ticker, DFS, has recently experienced an increase in its short interest, rising to 10.94% since the last report. The total number of shares sold short now stands at 3.11 million, equating to 1.42% of the available shares for trading. If we consider the current trading volume, it would...

Continue Reading
Immunic Reaches Key Milestone in Multiple Sclerosis Trials

Updated Category News Views 201

Immunic Completes Enrollment in Phase 3 Trials Immunic, Inc. (NASDAQ: IMUX), a pioneering biotechnology firm, recently reached a significant milestone by completing enrollment for its Phase 3 ENSURE trials, which focus on its lead drug, vidofludimus calcium. These trials target patients living with relapsing multiple sclerosis (RMS) and aim to evaluate the drug's...

Continue Reading
Ergonomic Apparel Revolution: Elevating Back Health in Daily Life

Updated Category News Views 86

Rising Trend of Ergonomic Posture Wear The growing trend of ergonomic apparel highlights the importance of posture-related health concerns. As people spend more time seated and engaged with screens, discomfort is becoming increasingly common. A recent review has brought attention to this phenomenon, shedding light on how ergonomic clothing can play a pivotal role in...

Continue Reading